Instrument Business Outlook Volume 30 - Issue 13

15 Oct 2021
Table of Contents
  • AACC 2021 Features In-Person and Virtual Options
    • Scientific Sessions
    • New Products
  • Lab Automation: A Crucial Technology for Pharma and Biotech Companies and CROs
  • Executive Briefing
    • Thermo Fisher–PPD Deal May Face UK Scrutiny
    • Thermo Fisher Names New COO
    • Henrietta Lacks Estate Sues Thermo Fisher
    • Oxford Nanopore Ups 2021 Guidance and Avantor and Berkeley Lights Release Preliminary Third Quarter Results
    • Bionano Genomics Adds Software Expertise
    • IsoPlexis Completes IPO
    • PHC Lists on Tokyo Exchange
    • BICO Makes Two More Purchases
    • Tosoh Bioscience Completes Purchase of Process LC Firm
  • Second Quarter Results: Fluidigm, HORIBA, NanoString Technologies and Spectris
    • Fluidigm Third Quarter Sales Led by EMEA Region
    • HORIBA Reaffirms Initial 2021 Sales Guidances After Strong Quarterly Growth
    • NanoString Posts Strong Quarterly Sales Growth for Both GeoMx DSP and nCounter
    • Spectris’ Malvern Panalytical Business Post Strength
  • Market Profile: RNA Interference (RNAi)
    • Leading Vendors
    • Largest Markets
  • Industry Watch
    • Clinical
    • Pharma/Biotech
    • Food
  • Region Watch
    • Russia
    • Japan
    • Argentina
  • News
    • Broad-Based Companies
      • Company Announcements
    • Chromatography
      • Company Announcements
      • Product Introductions
      • Sales & Orders of Note
    • Life Science Consumables
      • Company Announcements
      • Product Introductions
      • Gene-Based Analysis
      • Company Announcements
      • Product Introductions
      • Sales & Orders of Note
      • Cell-Based Analysis
      • Company Announcements
      • Product Introductions
      • Protein-Based Analysis
      • Company Announcements
      • Product Introductions
    • Bioprocess Analysis
      • Company Announcements
      • Product Introductions
      • Sales & Orders of Note
    • Process Analysis
      • Company Announcements
  • Bottom Line